Rincon-Torroella, Jordina
Rakovec, Maureen
Kalluri, Anita L.
Jiang, Kelly
Weber-Levine, Carly
Parker, Megan
Raj, Divyaansh
Materi, Josh
Sepehri, Sadra
Ferres, Abel
Schreck, Karisa C.
Aldecoa, Iban
Lucas, Calixto-Hope G.
Sair, Haris I.
Redmond, Kristin J.
Holdhoff, Matthias
Weingart, Jon
Brem, Henry
Sánchez, Josep J. González
Ye, Xiaobu
Bettegowda, Chetan
Funding for this research was provided by:
Johns Hopkins School of Medicine Biostatistics, Epidemiology, and Data Management (BEAD) Core.
NINDS (5R25NS065729)
Article History
Received: 26 July 2024
Accepted: 10 September 2024
First Online: 9 October 2024
Declarations
:
: This study was approved by the Johns Hopkins Institutional Review Board (IRB00282685). Informed consent was waived due to the retrospective, non-interventional design of this study.
: On behalf of all authors, the corresponding author states no conflicts of interest. KJR: Research support from Elekta AB, Accuray and Canon; Data Safety Monitoring Board for BioMimetix; Travel expenses from Brainlab, Elekta AB, Accuray and Icotec; Consulting fees Icotec. MH: Parexel - data safety monitoring board; Advarra - data safety monitoring board; Bayer, AnHeart Therapeutics Inc, and Servier -- advisory board.
: We found no applicable reporting guidelines that would apply to this article. By following the EQUATOR reporting guidelines decision tree, (), we found that none of the most popular checklists are appropriate for our study design.